Delivery Order 36C24226D0037-36C24226N0381
- Not listed
- Nuclear Diagnostic Products, Inc. was awarded a two-year, firm fixed price delivery order valued at approximately $1.9 million by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 2 (VA VHA VISN 2) to provide general radiopharmaceuticals. The contract has a period of performance starting February 22, 2021 through February 21, 2023, with all work to be conducted by the prime contractor at its facility located in Rockaway, New Jersey. No major...
- This federal contract award was issued by the U.S. Department of Veterans Affairs (VA) to Nuclear Diagnostic Products, Inc., a for-profit company specializing in the supply of radiopharmaceuticals for the VA healthcare system. The $111,392.95 delivery order is part of a larger Indefinite Delivery Contract (IDC) worth $4,038,178.15 with the VA's Veterans Integrated Service Network (VISN) 2 for general radiopharmaceuticals, with a performance period through February 2026. The contract does not...
- The Department of Veterans Affairs (VA) has awarded a firm fixed price delivery order contract to Nuclear Diagnostic Products, Inc., a for-profit organization, to provide general radiopharmaceuticals for the VA's Veterans Integrated Service Network (VISN) 2, which covers facilities in New York and New Jersey. This $610,950.85 contract has a completion date of February 21, 2024. Nuclear Diagnostic Products, Inc. is the prime contractor and has been awarded numerous similar contracts by the VA...
- This is a firm fixed price delivery order awarded by the U.S. Department of Veterans Affairs (VA) to Nuclear Diagnostic Products, Inc., a for-profit organization that provides radiopharmaceuticals used in nuclear medicine procedures. The $288,366.34 contract is for the supply of radiopharmaceuticals to VA medical centers in Veterans Integrated Service Networks (VISNs) 2 and 4, which cover facilities in New York, New Jersey, Pennsylvania, and Delaware. The award is not set aside for any...
- This is a delivery order awarded by the U.S. Department of Veterans Affairs (VA) to Nuclear Diagnostic Products, Inc., a for-profit organization specializing in the supply of radiopharmaceuticals. The contract, valued at $174,071.55, is for the delivery of general radiopharmaceuticals to support nuclear medicine imaging procedures across the VA's Veterans Integrated Service Network (VISN) 2, which covers facilities in the northeastern United States. This contract is part of a larger Indefinite...
- The U.S. Department of Veterans Affairs Veterans Integrated Service Network 4 (VISN 4) awarded a delivery order modification to Nuclear Diagnostic Products, Inc. on March 15, 2025, to increase contract line item numbers (CLINs) for radiopharmaceutical products. The award, valued at $374.3K, is issued as a firm fixed-price delivery order against an existing Indefinite Delivery Contract (IDC) with a ceiling value through November 2027. This delivery order is not set-aside and will be performed...
- This federal contract award, valued at $103,865.20, was issued by the U.S. Department of Veterans Affairs (VA) to Nuclear Diagnostic Products, Inc. for the provision of general radiopharmaceuticals to support the Veterans Integrated Service Network (VISN) 2 healthcare system. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by the company, which provides specialized radiopharmaceutical products to VA medical centers in the northeastern United States....
- This is a firm-fixed-price delivery order contract awarded by the U.S. Department of Veterans Affairs (VA) to Nuclear Diagnostic Products, Inc., a for-profit organization specializing in the supply of radiopharmaceuticals. The contract, valued at $330,602.10, is for the provision of general radiopharmaceuticals to support nuclear medicine imaging procedures across the VA's Veterans Integrated Service Network (VISN) 2, which covers facilities primarily in the northeastern United States. The...
- This is a federal delivery order contract awarded by the U.S. Department of Veterans Affairs (VA) to Nuclear Diagnostic Products, Inc., a for-profit organization specializing in radiopharmaceutical supplies. The contract, valued at $215,958.40, is for the provision of general radiopharmaceuticals to support nuclear medicine imaging procedures within the VA's Veterans Integrated Service Network (VISN) 2, which covers facilities in the northeastern United States. The contract is a firm fixed-price...
- This is a delivery order contract awarded by the U.S. Department of Veterans Affairs (VA) to Nuclear Diagnostic Products, Inc., a for-profit organization based in Rockaway, New Jersey. The contract is for the supply of radiopharmaceuticals, which are specialized medical imaging compounds used in nuclear medicine diagnostic procedures such as positron emission tomography (PET) and single-photon emission computed tomography (SPECT) scans. The contract has a ceiling value of $253,728.12 and is a...
- 36C24226D0037Indefinite Delivery Contract
- 36C24226D0037-36C24226N0381Delivery Order
Nuclear Diagnostic Products, Inc. has been awarded a delivery order valued at $959,170.05 for the supply of radiopharmaceuticals to Veterans Integrated Service Network 2 (VISN 2), a civilian healthcare network within the U.S. Department of Veterans Affairs. The contract, issued on February 24, 2026, is structured as a firm fixed-price delivery order with an ultimate completion date of December 31, 2026, and carries no small business set-aside designation. The work will be performed in Rockaway, New Jersey, where the contractor maintains its headquarters. This delivery order is issued against an existing Indefinite Delivery Contract (IDC) with VA-VHA VISN 2 valued at approximately $4.04 million for general radiopharmaceuticals, demonstrating the contractor's established relationship as a key supplier for VA diagnostic imaging programs. Nuclear Diagnostic Products, Inc. specializes in supplying critical medical imaging compounds used in nuclear medicine diagnostics, including specialized radiopharmaceuticals such as ILLUCCIX (Gallium 68 PSMA-11) and GA-68 NETSPOT, which are utilized in positron emission tomography and single-photon emission computed tomography scans. As a registered federal contractor since 2006, the company has consistently provided radiopharmaceutical products to support diagnostic services for veterans across multiple service networks in the northeastern United States. The radiopharmaceutical products delivered under this order will support VA medical imaging programs and diagnostic procedures at VA medical facilities across New York and New Jersey, contributing to the Veterans Health Administration's diagnostic capabilities and healthcare services for the veteran population.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $959.2k | 2/23/26 |